As of September 12, 2024, New Jersey is the latest state to regulate “intoxicating hemp products” with the passage of Senate Bill 3235. The new law prohibits the sale of THC-containing hemp products to minors and only allows...more
With an expanding cannabis and hemp market and an upcoming legislative session that will consider medical cannabis expansion, hemp regulation, decriminalization, and other cannabis matters—we have our eyes on Texas! Texas...more
July 22, marked the end of the historic DEA public comment period for marijuana’s proposed rescheduling to Schedule III. Industry engagement was strong, and thanks to the efforts of advocacy organizations, industry...more
After 50 years of being on the most restrictive schedule alongside drugs like heroin and PCP, the DEA will move to reschedule marijuana in Schedule III, where the plant’s medical benefits will finally be recognized by the...more
5/1/2024
/ Agribusiness ,
Controlled Substances Act ,
Corporate Counsel ,
DEA ,
Decriminalization of Marijuana ,
Department of Justice (DOJ) ,
Financial Services Industry ,
Food and Drug Administration (FDA) ,
Marijuana ,
Marijuana Related Businesses ,
Medical Marijuana ,
Medical Research ,
Popular ,
Schedule I Drugs
With one of the largest consumable hemp markets in the country, Texas is a key state to watch in the ever-evolving world of hemp regulation. While many other states regulate or prohibit synthetics, establish THC mg limits on...more
On August 30, 2023, the federal government formally acknowledged the medical use and low potential of abuse for cannabis, with the US Department of Health and Human Services (HHS) recommending that cannabis be rescheduled to...more
9/1/2023
/ Biden Administration ,
Cannabis-Related Businesses (CRBs) ,
Controlled Substances Act ,
Criminal Justice Reform ,
DEA ,
Decriminalization of Marijuana ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Drug Treatment ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Internal Revenue Code (IRC) ,
IRS ,
Medical Marijuana ,
Medical Research ,
Pharmaceutical Industry ,
Popular ,
Schedule I Drugs ,
Tax Penalties
As of January 2019, all consumable CBD products—including extracts and isolates—were confirmed as novel foods for England and Wales, and therefore must be approved by the Food Standards Agency (FSA) before they can be sold...more
On May 4, 2022, the FDA issued five warning letters to companies for selling products containing hemp-derived Delta-8 THC. Notably, this is the first time the FDA has issued warning letters specifically for Delta-8 products....more
Watch this recorded session exploring trending topics in the hemp industry. During the session, members of our hemp team discussed the legality, regulation, and lawsuits surrounding minor cannabinoids (including...more
4/25/2022
/ Cannabidiol (CBD) oil ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Dispensaries ,
Farm Bill ,
Hemp ,
Hemp Cultivation ,
Hemp Related Businesses ,
Marijuana ,
Marijuana Cultivation ,
Marijuana Related Businesses ,
THC
Hemp was federally legalized nearly four years ago. Since then, the industry has dealt with constantly changing rules, despite being in regulatory purgatory due to snail-paced progress from the U.S. Food & Drug Administration...more
1/7/2022
/ ATF ,
Cannabidiol (CBD) oil ,
Cannabis Products ,
Consumer Protection Laws ,
Department of Agriculture ,
Dietary Supplements ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Hemp ,
Hemp Cultivation ,
Hemp Related Businesses ,
Marijuana-Infused Edibles ,
THC
Almost three years since the legalization of hemp production in the United States, the U.S. Food and Drug Administration (FDA) is still in the process of determining the regulatory framework for CBD and other hemp...more
On July 14, 2021, Senators Chuck Schumer (D-NY), Ron Wyden (D-OR), and Cory Booker (D-NJ) released the discussion draft of historic federal cannabis legalization legislation, the Cannabis Administration and Opportunity Act...more
7/29/2021
/ ATF ,
Cannabidiol (CBD) oil ,
Cannabis-Related Businesses (CRBs) ,
Controlled Substances Act ,
Dietary Supplements ,
Excise Tax ,
Expungement ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Funding ,
Hemp ,
Labeling ,
Marijuana ,
Popular ,
Public Comment ,
THC ,
TTB ,
USDA